770 related articles for article (PubMed ID: 12371966)
21. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.
Kitching AR; Katerelos M; Mudge SJ; Tipping PG; Power DA; Holdsworth SR
Clin Exp Immunol; 2002 Apr; 128(1):36-43. PubMed ID: 11982588
[TBL] [Abstract][Full Text] [Related]
23. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis.
Dimmler A; Haas CS; Cho S; Hattler M; Forster C; Peters H; Schöcklmann HO; Amann K
Diagn Mol Pathol; 2003 Jun; 12(2):108-17. PubMed ID: 12766616
[TBL] [Abstract][Full Text] [Related]
24. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.
Bianco F; Fumagalli M; Pravettoni E; D'Ambrosi N; Volonte C; Matteoli M; Abbracchio MP; Verderio C
Brain Res Brain Res Rev; 2005 Apr; 48(2):144-56. PubMed ID: 15850653
[TBL] [Abstract][Full Text] [Related]
26. Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells.
Harada H; Chan CM; Loesch A; Unwin R; Burnstock G
Kidney Int; 2000 Mar; 57(3):949-58. PubMed ID: 10720948
[TBL] [Abstract][Full Text] [Related]
27. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
[TBL] [Abstract][Full Text] [Related]
29. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
30. Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis.
Jyo-Oshiro Y; Sasaki T; Kawakami Y; Nohno T; Itoh N; Osawa G; Kashihara N
Virchows Arch; 1999 Nov; 435(5):501-8. PubMed ID: 10592054
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis.
Hartner A; Pahl A; Brune K; Goppelt-Struebe M
Inflamm Res; 2000 Jul; 49(7):345-54. PubMed ID: 10959556
[TBL] [Abstract][Full Text] [Related]
32. [Expression of FGF2, FGF receptor-1 and alpha-smooth muscle actin in experimental mesangial proliferative nephritis].
Jyo Y
Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):545-54. PubMed ID: 9014473
[TBL] [Abstract][Full Text] [Related]
33. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
Peters H; Eisenberg R; Daig U; Liefeldt L; Westenfeld R; Gaedeke J; Krämer S; Neumayer HH
Kidney Int; 2004 Jun; 65(6):2238-48. PubMed ID: 15149337
[TBL] [Abstract][Full Text] [Related]
34. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.
Pichler RH; Bassuk JA; Hugo C; Reed MJ; Eng E; Gordon KL; Pippin J; Alpers CE; Couser WG; Sage EH; Johnson RJ
Am J Pathol; 1996 Apr; 148(4):1153-67. PubMed ID: 8644857
[TBL] [Abstract][Full Text] [Related]
35. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis.
Haseley LA; Hugo C; Reidy MA; Johnson RJ
Kidney Int; 1999 Sep; 56(3):964-72. PubMed ID: 10469364
[TBL] [Abstract][Full Text] [Related]
37. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis.
Monkawa T; Pippin J; Yo Y; Kopp JB; Alpers CE; Shankland SJ
Nephron Exp Nephrol; 2006; 102(1):e8-18. PubMed ID: 16179805
[TBL] [Abstract][Full Text] [Related]
38. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
[TBL] [Abstract][Full Text] [Related]
39. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo.
Grande JP; Walker HJ; Holub BJ; Warner GM; Keller DM; Haugen JD; Donadio JV; Dousa TP
Kidney Int; 2000 Mar; 57(3):1027-40. PubMed ID: 10720955
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis.
Budisavljevic MN; Hodge L; Barber K; Fulmer JR; Durazo-Arvizu RA; Self SE; Kuhlmann M; Raymond JR; Greene EL
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1138-48. PubMed ID: 14600028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]